NCT02577120View on ClinicalTrials.gov

Wound Healing Endpoint and Recurrence

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

February 28, 2029

Study Completion Date

February 28, 2034

Conditions
Chronic WoundBurn WoundDiabetic Foot UlcersPressure UlcersVenous Leg UlcersChronicWound
Interventions
DEVICE

Epiceram Skin Barrier Function

Epiceram is a non-sterile, viscous, lipid-rich emulsion

BIOLOGICAL

Vaseline Petroleum Jelly

A skin protectant used for temporarily protecting minor cuts, scraps, burns, and helps to protect and help relieve chapped or cracked skin and lips.

Trial Locations (3)

15132

University of Pittsburgh / McKeesport Clinic, Pittsburgh

15219

University of Pittsburgh / Mercy Clinic, Pittsburgh

16066

University of Pittsburgh / Passavant, Pittsburgh

All Listed Sponsors
lead

Sashwati Roy

OTHER

NCT02577120 - Wound Healing Endpoint and Recurrence | Biotech Hunter | Biotech Hunter